Related Experiment Video

Updated: Jul 22, 2026

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

Extracellular proteases as targets for treatment of cancer metastases

Mijoon Lee1, Rafael Fridman, Shahriar Mobashery

  • 1Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.

Chemical Society Reviews
|September 9, 2004
PubMed

Insights

Metastasis, the spread of cancer cells, involves protease enzymes that degrade tissue. Inhibiting these proteases, like matrix metalloproteinases (MMPs), shows therapeutic promise for treating metastatic cancer.

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Metastasis, the spread of cancer cells, is a primary cause of cancer mortality.
  • Extracellular matrix degradation by proteases is crucial for metastatic dissemination.
  • Matrix metalloproteinases (MMPs), serine, and cysteine proteases are implicated in metastasis.

Purpose of the Study:

  • To review enzyme inhibition strategies for combating cancer metastasis.
  • To discuss novel drug design approaches targeting proteases in metastatic disease.

Main Methods:

  • Literature review of protease inhibitors in cancer metastasis.
  • Analysis of therapeutic effects in preclinical metastasis models.
  • Examination of new drug development for protease inhibition.

Main Results:

  • Enzyme inhibition, particularly of MMPs, has demonstrated significant therapeutic effects in animal models.
  • Various strategies for enzyme inhibition are effective.
  • New drug designs are emerging for protease inhibition in metastatic cancer.

Conclusions:

  • Targeting proteases represents a promising therapeutic avenue for managing cancer metastasis.
  • Continued development in drug design offers potential for improved anti-metastasis therapies.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: